InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (16 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
16
T+90 hit rate
100%
T+90 mean return
+6.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Bitterman Kevin, Director. Director active across 3 companies, notably Akero Therapeutics, Inc.. In total, 20 filings have been published. Breakdown: 1 buy · 16 sells. Total volume traded: €27.3m. Activity tracked since 1 June 2021. The latest transaction was filed on 17 December 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bitterman Kevin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
393 shares@ US$91.470.1% of flowCommon StockSEC:0001591747-25-000008:0
16,403 shares@ US$92.054.8% of flowCommon StockSEC:0001104659-25-121740:0
19,542 shares@ US$77.165.1% of flowCommon StockSEC:0001591747-25-000006:0
11,378 shares@ US$68.012.7% of flowCommon StockSEC:0001591747-25-000004:0
2,287 shares@ US$61.030.6% of flowCommon StockSEC:0001415889-25-023049:0
24,962 shares@ US$61.155.5% of flowCommon StockSEC:0001415889-25-022124:0
395 shares@ US$60.950.1% of flowCommon StockSEC:0001415889-25-021281:0
8,492 shares@ US$61.042.0% of flowCommon StockSEC:0001415889-25-020863:0
29,837 shares@ US$60.977.1% of flowCommon StockSEC:0001415889-25-020295:0
664 shares@ US$61.130.2% of flowCommon StockSEC:0001415889-25-020127:0
222,223 shares@ US$36.0036.6% of flowCommon StockSEC:0001415889-24-017727:0
Canonical exit: 15 Sept 2024 (T+90)
26,157 shares@ US$73.508.7% of flowCommon StockSEC:0001415889-24-007190:0
82,500 shares@ US$67.6525.2% of flowCommon StockSEC:0001209191-24-002233:0
20,000 shares@ US$64.005.8% of flowCommon StockSEC:0001209191-24-001543:0
20,823 shares@ US$59.875.7% of flowCommon StockSEC:0001209191-23-058708:0
72,931 shares@ US$52.4017.2% of flowCommon StockSEC:0001209191-23-046252:0
16,544 shares@ US$26.28100.0% of flowCommon StockSEC:0001209191-21-037978:0
2,549,435 sharesCommon StockSEC:0001179110-16-018856:0
2,021,269 sharesCommon StockSEC:0001179110-16-018856:1
85,469 sharesCommon StockSEC:0001179110-16-018856:2
20 of 20 declarations
About Bitterman Kevin
Bitterman Kevin is Administrateur at Disc Medicine, Inc., Editas Medicine, Inc. and Akero Therapeutics, Inc. Across 20 filings in total, the 20 sampled filings span from 2016-02-09 to 2025-12-18, with EUR 7,448,346 of buys and EUR 19,843,111 of sells, and the modal transaction nature is Sale.
